Related Experiment Videos
Chronic obstructive pulmonary disease: molecular and cellular mechanisms
P J Barnes1, S D Shapiro, R A Pauwels
1National Heart and Lung Institute, Imperial College, School of Medicine, London, UK. p.j.barnes@imperial.ac.uk
The European Respiratory Journal
|October 30, 2003
Summary
Chronic obstructive pulmonary disease (COPD) involves chronic inflammation and tissue damage, driven by cellular responses to cigarette smoke. Current treatments are limited as COPD inflammation is corticosteroid-resistant, necessitating new therapies.
Area of Science:
- Pulmonology
- Cellular Biology
- Molecular Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity.
- COPD pathogenesis involves chronic airway inflammation and alveolar destruction (emphysema).
- Key cellular players include macrophages, neutrophils, and T-lymphocytes, releasing inflammatory mediators.
Purpose of the Study:
- To explore the cellular and molecular mechanisms underlying COPD.
- To understand the inflammatory pathways and proteolytic processes in COPD.
- To identify potential targets for novel anti-inflammatory therapies.
Main Methods:
- Analysis of cellular infiltration in COPD lungs.
- Measurement of inflammatory mediator release.
- Assessment of elastolytic enzyme activity.
Main Results:
- Increased numbers of macrophages, neutrophils, and cytotoxic T-lymphocytes observed.
- Elevated levels of lipids, chemokines, cytokines, and growth factors detected.
- Evidence of increased elastolysis implicating serine proteases, cathepsins, and MMPs.
Conclusions:
- COPD inflammation is an amplified response to cigarette smoke.
- This inflammation is resistant to corticosteroids, unlike asthma.
- Novel anti-inflammatory strategies are needed to halt COPD progression.